These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3896612)

  • 21. A preliminary pharmacokinetic study of cyclosporine A in 10 Japanese renal transplant patients.
    Takada K; Yoshikawa H; Muranishi S; Nagano S; Fukunishi T
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):438-42. PubMed ID: 3308718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between cyclosporine and fluconazole in renal allograft recipients.
    Canafax DM; Graves NM; Hilligoss DM; Carleton BC; Gardner MJ; Matas AJ
    Transplantation; 1991 May; 51(5):1014-8. PubMed ID: 2031258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of nephrotoxic cyclosporine peak concentrations by daily drug division in 3 equal oral portions.
    Zazgornik J; Schindler J; Balcke P; Kopsa H; Gremmel F; Derfler K; Kretschmer G; Mühlbacher F; Piza F
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):197-200. PubMed ID: 3294613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of cyclosporine G in patients with renal failure.
    Wenk M; Bindschedler M; Costa E; Zuber M; Vozeh S; Thiel G; Abisch E; Keller HP; Beveridge T; Follath F
    Transplantation; 1988 Mar; 45(3):558-61. PubMed ID: 3347936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine concentration determinations for monitoring and pharmacokinetic studies.
    Ptachcinski RJ; Burckart GJ; Venkataramanan R
    J Clin Pharmacol; 1986; 26(5):358-66. PubMed ID: 3517078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases.
    Kahan BD; Lorber MI; Flechner SM; Van Buren CT; Jensen C; Wideman CA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):59-65. PubMed ID: 3515696
    [No Abstract]   [Full Text] [Related]  

  • 27. Disposition of nomifensine after acute and prolonged dosing.
    Lindberg RL; Syvälahti EK; Pihlajamäki KK
    Clin Pharmacol Ther; 1986 Apr; 39(4):384-8. PubMed ID: 3956055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-dependent cyclosporine: pharmacokinetics in marrow transplant recipients.
    Yee GC; Lennon TP; Gmur DJ; Kennedy MS; Deeg HJ
    Clin Pharmacol Ther; 1986 Oct; 40(4):438-43. PubMed ID: 3530588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of constant-rate intravenous cyclosporine infusion immediately after heart transplantation.
    Schroeder TJ; Myre SA; Melvin DB; Van der Bel-Kahn J; Stephens GW; Collins JA; Wolf RK; Brown LL; Pesce AJ; First MR
    J Heart Transplant; 1989; 8(1):5-10. PubMed ID: 2647932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and nephrotoxicity of cyclosporine in renal transplant recipients.
    Henny FC; Kleinbloesem CH; Moolenaar AJ; Paul LC; Breimer DD; van Es LA
    Transplantation; 1985 Sep; 40(3):261-5. PubMed ID: 3898491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.
    D'mello A; Venkataramanan R; Satake M; Todo S; Takaya S; Ptachcinski RJ; Burckart GJ; Starzl TE
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):441-54. PubMed ID: 2781141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of calcium-channel blockers on cyclosporine clearance and use in renal transplant patients.
    Sketris IS; Methot ME; Nicol D; Belitsky P; Knox MG
    Ann Pharmacother; 1994 Nov; 28(11):1227-31. PubMed ID: 7849332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Area under the curve monitoring of cyclosporine therapy: the early posttransplant period.
    Grevel J; Kahan BD
    Ther Drug Monit; 1991 Mar; 13(2):89-95. PubMed ID: 2053129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients.
    Gupta SK; Legg B; Solomon LR; Johnson RW; Rowland M
    Br J Clin Pharmacol; 1987 Oct; 24(4):519-26. PubMed ID: 3318898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects and side effects of cyclosporine: relationship to drug pharmacokinetics.
    Keown PA; Stiller CR; Laupacis AL; Howson W; Coles R; Stawecki M; Koegler J; Carruthers G; McKenzie N; Sinclair NR
    Transplant Proc; 1982 Dec; 14(4):659-61. PubMed ID: 6762722
    [No Abstract]   [Full Text] [Related]  

  • 36. Blood protein binding of cyclosporine in transplant patients.
    Zaghloul I; Ptachcinski RJ; Burckart GJ; Van Thiel D; Starzel TE; Venkataramanan R
    J Clin Pharmacol; 1987 Mar; 27(3):240-2. PubMed ID: 3316307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics of cyclosporine A in uremic patients.
    Lindberg A; Odlind B; Tufveson G; Lindström B; Gabrielsson J
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):144-52. PubMed ID: 3787709
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporine pharmacokinetics in liver transplant recipients: evaluation of results using both polyclonal radioimmunoassay and liquid chromatographic analysis.
    Tredger JM; Grevel J; Naoumov N; Steward CM; Niven AA; Whiting B; Williams R
    Eur J Clin Pharmacol; 1991; 40(5):513-9. PubMed ID: 1884727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of bile on cyclosporine absorption in dogs.
    Venkataramanan R; Perez HD; Schwinghammer T; Burckart GJ; Ptachcinski RJ; Van Thiel DH; Starzl TE
    Res Commun Chem Pathol Pharmacol; 1986 Jul; 53(1):137-40. PubMed ID: 3749608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic aspects of cyclosporine therapy: pharmacokinetics.
    Wood AJ; Lemaire M
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):27-32. PubMed ID: 3895666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.